Literature DB >> 33761730

The risk assessment model of fracture nonunion after intramedullary nailing for subtrochanteric femur fracture.

ZhengHao Wang1, KaiNan Li1, ZuChao Gu2, HaiQuan Fan3, HaiBo Li4.   

Abstract

ABSTRACT: To investigate the influencing factors of fracture nonunion after intramedullary nailing for subtrochanteric fractures and to construct a risk assessment model.Based on the multicenter retrospective analysis of 251 patients, all patients were divided into modeling group and verification group. In the modeling group, postoperative fracture nonunion rate, general data, fracture-related factors, surgical reduction-related factors, mechanical and biological factors were calculated, and the influencing factors of fracture nonunion were screened by univariate analysis. Logistic regression model was used for multifactor analysis to construct the risk assessment model. Based on the logistic regression model, the risk prediction model was constructed by drawing the Nomogram diagram. Through the verification group, the influencing factors were evaluated again, and the differentiation and calibration of the model were evaluated. The calibration degree was evaluated by Hosmer-Lemeshow test, goodness of fit test, and calibration curve. The discriminant degree was evaluated by the receiver operating characteristic curve.Fracture nonunion occurred in 34 of 149 patients in the modeling group. Among the 14 potential influencing factors, univariate analysis and logistic regression analysis showed that postoperative hip varus, intramedullary nail fixation failure, and reduction of fracture with large incision were the risk factors of fracture nonunion. The medial cortex fracture was seen reduced on X-Ray was a protective factor for fracture nonunion, and a regression equation was established. Based on the logistic regression model, the Nomogram diagram is drawn. Twenty-four cases of fracture nonunion occurred in the verification group. The area under the receiver operating characteristic curve was area under curve =0.883 > 0.7, indicating that there was a moderate differentiation to evaluate the occurrence of fracture nonunion after operation. The goodness of fit test: the Hosmers-Lemeshow test (X2 = 2.921, P = .712 > .05) showed that the model had a good calibration.After intramedullary nailing of subtrochanteric fracture, hip varus, failure of intramedullary nail fixation and wide surgical dissection are the risk factors of fracture nonunion, and the postoperative reduction of medial cortex fracture is protective factor.National key research and development projects: 2016YFC0105806.
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Year:  2021        PMID: 33761730      PMCID: PMC9282089          DOI: 10.1097/MD.0000000000025274

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


  25 in total

1.  Outcome of traumatic subtrochanteric femoral fractures fixed using cephalo-medullary nails.

Authors:  Sourav Shukla; Phillip Johnston; M A Ahmad; Henry Wynn-Jones; A D Patel; N P Walton
Journal:  Injury       Date:  2007-11-05       Impact factor: 2.586

2.  Percutaneous cerclage wiring followed by intramedullary nailing for subtrochanteric femoral fractures: a technical note with clinical results.

Authors:  Joon-Woo Kim; Ki-Chul Park; Jong-Keon Oh; Chang-Wug Oh; Yong-Cheol Yoon; Hyo-Won Chang
Journal:  Arch Orthop Trauma Surg       Date:  2014-06-11       Impact factor: 3.067

3.  [Subtrochanteric femoral fractures].

Authors:  B Ulmar; S Simon; A Eschler; T Mittlmeier
Journal:  Unfallchirurg       Date:  2013-12       Impact factor: 1.000

4.  Subtrochanteric fractures: treatment with cerclage wire and long intramedullary nail.

Authors:  Jordi Tomás; Jordi Teixidor; Lledó Batalla; Daniel Pacha; Josep Cortina
Journal:  J Orthop Trauma       Date:  2013-07       Impact factor: 2.512

Review 5.  Contemporary management of subtrochanteric fractures.

Authors:  Siddharth B Joglekar; Eric M Lindvall; Armen Martirosian
Journal:  Orthop Clin North Am       Date:  2014-10-18       Impact factor: 2.472

6.  Biological fixation of comminuted subtrochanteric fractures with proximal femur locking compression plate.

Authors:  Pramod Saini; Rakesh Kumar; Vishal Shekhawat; Narendra Joshi; Mahesh Bansal; Senthil Kumar
Journal:  Injury       Date:  2012-11-30       Impact factor: 2.586

7.  Inadequate 'three-point' proximal fixation predicts failure of the Gamma nail.

Authors:  S G F Abram; T C B Pollard; A J M D Andrade
Journal:  Bone Joint J       Date:  2013-06       Impact factor: 5.082

8.  Sliding hip screw versus IM nail in reverse oblique trochanteric and subtrochanteric fractures. A study of 2716 patients in the Norwegian Hip Fracture Register.

Authors:  Kjell Matre; Leif Ivar Havelin; Jan-Erik Gjertsen; Tarjei Vinje; Birgitte Espehaug; Jonas Meling Fevang
Journal:  Injury       Date:  2013-01-08       Impact factor: 2.586

9.  Factors Affecting Time to Bony Union of Femoral Subtrochanteric Fractures Treated with Intramedullary Devices.

Authors:  Jung-Yoon Choi; Yerl-Bo Sung; Jin-Hee Yoo; Sung-Jae Chung
Journal:  Hip Pelvis       Date:  2014-06-30

10.  Nonunion of subtrochanteric fractures: Comminution or Malreduction.

Authors:  Sang Hyun Park; Gyu Min Kong; Byeong Ho Ha; Jun Ho Park; Kun Hyung Kim
Journal:  Pak J Med Sci       Date:  2016 May-Jun       Impact factor: 1.088

View more
  2 in total

1.  Subtrochanteric femoral fractures: A case series of 194 patients treated with long and short intramedullary nails.

Authors:  Eugenio Jannelli; Cristina Ghia; Medetti Marta; Gianluigi Pasta; Alessandro Ivone; Ester Boggio; Gianluca Conza; Fabio Zanchini; Federico Alberto Grassi; Mario Mosconi
Journal:  Orthop Rev (Pavia)       Date:  2022-10-13

2.  The Clinical Efficacy of Minimally Invasive Clamp-Assisted Reduction and Open Reduction with Wire Cerclage for Unstable Subtrochanteric Fractures.

Authors:  Dong Liu; Hong-Zhi Liu; Ming-Liang Ma; Nan Zhou; Hui Wang
Journal:  J Healthc Eng       Date:  2022-01-25       Impact factor: 2.682

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.